CRDB Bank Plc (DAR:CRDB)

CTI BioPharma Balance Sheet

Financials in millions TZS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	575,980	2,826,008	1,337,549	1,286,257	1,150,564	784,857
Investment Securities	2,358,514	1,393,666	2,012,230	1,840,858	1,353,372	1,410,327
Trading Asset Securities	-	15,428	9,266	16,417	20,807	-
Total Investments	2,358,514	1,409,094	2,021,496	1,857,275	1,374,179	1,410,327
Gross Loans	12,937,649	10,506,271	8,569,310	7,043,101	5,177,235	4,077,523
Allowance for Loan Losses	-173,564	-143,445	-123,510	-165,344	-135,023	-147,898
Net Loans	12,764,085	10,362,826	8,445,800	6,877,757	5,042,212	3,929,625
Property, Plant & Equipment	453,315	455,242	440,282	401,558	413,596	381,389
Other Intangible Assets	-	105,328	73,645	40,800	25,174	30,026
Other Receivables	1,306,988	103,804	212,024	140,785	98,539	111,957
Restricted Cash	1,674,464	469,860	375,128	389,684	231,350	229,963
Other Current Assets	-	156,174	126,126	99,007	137,933	130,409
Long-Term Deferred Tax Assets	-	89,751	85,649	51,949	41,130	48,639
Other Long-Term Assets	574,029	711,999	195,322	491,485	302,882	113,280
Total Assets	19,707,375	16,698,751	13,321,289	11,636,557	8,817,559	7,170,472
Accrued Expenses	-	73,002	71,505	-	45,077	40,469
Interest Bearing Deposits	13,935,952	10,934,131	8,855,978	9,327,762	7,204,816	5,730,859
Total Deposits	13,935,952	10,934,131	8,855,978	9,327,762	7,204,816	5,730,859
Short-Term Borrowings	-	1,108,682	995,561	-	-	-
Current Portion of Long-Term Debt	-	102,572	67,278	68,051	58,251	29,492
Current Portion of Leases	-	1,757	1,375	952	10,406	2,096
Current Income Taxes Payable	107,331	6,827	-	-	-	-
Other Current Liabilities	51,105	281,704	245,998	-	66,146	44,472
Long-Term Debt	2,796,622	1,859,134	1,172,021	543,968	139,611	240,969
Long-Term Leases	-	61,307	48,442	30,485	27,270	27,522
Long-Term Unearned Revenue	150,707	18,470	21,536	3,012	4,730	6,132
Other Long-Term Liabilities	278,859	11,992	2,748	183,251	2,679	4,218
Total Liabilities	17,320,576	14,525,505	11,539,801	10,157,481	7,598,231	6,159,508
Common Stock	65,296	65,296	65,296	65,296	65,296	65,296
Additional Paid-In Capital	158,314	158,314	158,314	158,314	158,314	158,314
Retained Earnings	2,066,164	1,904,919	1,506,118	1,207,537	951,207	740,303
Comprehensive Income & Other	57,853	4,060	8,148	47,929	44,511	47,051
Total Common Equity	2,347,627	2,132,589	1,737,876	1,479,076	1,219,328	1,010,964
Minority Interest	39,172	40,657	43,612	-	-	-
Shareholders' Equity	2,386,799	2,173,246	1,781,488	1,479,076	1,219,328	1,010,964
Total Liabilities & Equity	19,707,375	16,698,751	13,321,289	11,636,557	8,817,559	7,170,472
Total Debt	2,796,622	3,133,452	2,284,677	643,456	235,538	300,079
Net Cash (Debt)	-2,220,642	-292,016	-937,862	659,218	935,833	484,778
Net Cash Growth	-	-	-	-29.56%	93.04%	28.31%
Net Cash Per Share	-852.46	-111.80	-359.06	252.38	358.28	185.60
Filing Date Shares Outstanding	2,622	2,612	2,612	2,612	2,612	2,612
Total Common Shares Outstanding	2,622	2,612	2,612	2,612	2,612	2,612
Book Value Per Share	895.42	816.51	665.38	566.30	466.85	387.07
Tangible Book Value	2,347,627	2,027,261	1,664,231	1,438,276	1,194,154	980,938
Tangible Book Value Per Share	895.42	776.18	637.19	550.68	457.21	375.57

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.